| 0.855 -0.068 (-7.37%) | 12-15 15:25 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.42 | 1-year : | 1.79 |
| Resists | First : | 1.21 | Second : | 1.53 |
| Pivot price | 1  |
|||
| Supports | First : | 0.69 | Second : | 0.58 |
| MAs | MA(5) : | 0.8 |
MA(20) : | 1.04 |
| MA(100) : | 1.65 |
MA(250) : | 0 | |
| MACD | MACD : | -0.2  |
Signal : | -0.2 |
| %K %D | K(14,3) : | 25.3 |
D(3) : | 14.6 |
| RSI | RSI(14): 35.7 |
|||
| 52-week | High : | 9.39 | Low : | 0.69 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ BMGL ] has closed above bottom band by 28.7%. Bollinger Bands are 60.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.06 - 1.07 | 1.07 - 1.08 |
| Low: | 0.75 - 0.76 | 0.76 - 0.76 |
| Close: | 0.94 - 0.95 | 0.95 - 0.96 |
Basel Medical Group Ltd provides healthcare services. The company offers services in the areas of medical specialists, medical supplies and equipment, medical technology, and pharmaceuticals. The company was incorporated in 2023 and is based in Singapore.
Tue, 03 Jun 2025
How To Stop Losing Money While Trading Stocks - timothysykes.com
Mon, 02 Jun 2025
Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket - Benzinga
Thu, 22 May 2025
Singapore-based Basel Medical takes the orange pill with $1B BTC plan - Cryptopolitan
Thu, 22 May 2025
Basel Medical Group Ltd Announces Strategic Purchase Agreement for 10,000 BTC to Diversify Treasury Reserves - Nasdaq
Fri, 16 May 2025
Pre-market Movers: IXHL, KLRS, HCTI, DOCS... - RTTNews
Wed, 19 Mar 2025
Basel Medical Group Ltd Completes Full Exercise of Overallotment Option in IPO, Raising Additional $1.32 Million - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Plans
|
|
| Shares Out | 19 (M) |
| Shares Float | 6 (M) |
| Held by Insiders | 54.3 (%) |
| Held by Institutions | 1.5 (%) |
| Shares Short | 235 (K) |
| Shares Short P.Month | 254 (K) |
| EPS | -0.5 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.2 |
| Profit Margin | -99.9 % |
| Operating Margin | -9.5 % |
| Return on Assets (ttm) | -4.7 % |
| Return on Equity (ttm) | -194.6 % |
| Qtrly Rev. Growth | 32.2 % |
| Gross Profit (p.s.) | 0.16 |
| Sales Per Share | 0.64 |
| EBITDA (p.s.) | -0.07 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -4 (M) |
| Levered Free Cash Flow | 4 (M) |
| PE Ratio | -1.73 |
| PEG Ratio | 0 |
| Price to Book value | 4.32 |
| Price to Sales | 1.34 |
| Price to Cash Flow | -3.75 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|